Amalaki, LLC – Trademark Portfolio

Entity Type: 16

Amalaki, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ZRII. The owner is based in Draper, UT.

Suite 201

Draper, UT 84020

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ZRII
ZRII
Registered 2007

Trademark Classifications

Amalaki, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Amalaki, LLC have?

Amalaki, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Amalaki, LLC file in?

Amalaki, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 32 (Light Beverages), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Amalaki, LLC's most well-known trademarks?

Amalaki, LLC's registered trademark portfolio includes well-known marks such as ZRII. These are among 1 currently registered trademark in the portfolio.

What is Amalaki, LLC's trademark registration success rate?

Amalaki, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.